Cargando…

Overexpression of HSD17B4 exerts tumor suppressive function in adrenocortical carcinoma and is not associated with hormone excess

AIM: Adrenocortical carcinoma (ACC) is characterized with excessive hormone production. We therefore investigated expression of hormone-related genes in ACC. RESULTS: We queried status of 14 key genes directly involved in adrenal hormone production and found HSD17B4 expression was upregulated in 39%...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Guanxiong, Liu, Shenghua, Ding, Qiang, Feng, Chenchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777728/ https://www.ncbi.nlm.nih.gov/pubmed/29383116 http://dx.doi.org/10.18632/oncotarget.22827

Ejemplares similares

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion
por: Liu, Shenghua, et al.
Publicado: (2018)

Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation
por: Hui, Wen, et al.
Publicado: (2018)

Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma Cells
por: Kroiss, Matthias, et al.
Publicado: (2011)

Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition
por: Ding, Guanxiong, et al.
Publicado: (2013)

Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020)

Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression
por: Xu, Yunze, et al.
Publicado: (2015)

THU574 Hsd17b1 Partially Compensates For The Lack Of Hsd17b3 In Testicular Testosterone Production In Fetal Mice, But Not In Adults
por: Poutanen, Matti, et al.
Publicado: (2023)

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma
por: Guillaud-Bataille, Marine, et al.
Publicado: (2014)

Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma
por: Feng, Chenchen, et al.
Publicado: (2014)

Metastatic Adrenocortical Carcinoma Co-Secreting Multiple Steroid Hormones
por: Lee, Tien-Hao, et al.
Publicado: (2021)

Need for Comprehensive Hormonal Workup in the Management of Adrenocortical Tumors in Children
por: Gönç, E. Nazlı, et al.
Publicado: (2014)

Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget’s Disease
por: Wang, Lujia, et al.
Publicado: (2017)

HSD17B13: A Potential Therapeutic Target for NAFLD
por: Zhang, Hai-bo, et al.
Publicado: (2022)

Adrenocortical Carcinoma
por: Berruti, Alfredo, et al.
Publicado: (2021)

Factors affecting adrenocortical hormone function.
por: Thompson, E B
Publicado: (1981)

PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways
por: Feng, Chenchen, et al.
Publicado: (2015)

Primary Aldosteronism as the Initial Presentation of Adrenocortical Multiple Hormone Producing Tumor
por: Uehara, Erika, et al.
Publicado: (2021)

SUN-213 Hsd17b3 Knockout Mice Serve As A Model To Define Mechanisms Behind The Altered Endocrine Phenotype Of Patients With Hsd17b3 Mutations
por: Poutanen, Matti, et al.
Publicado: (2019)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity
por: Ding, Guanxiong, et al.
Publicado: (2016)

Characterization of 17α-hydroxysteroid dehydrogenase activity (17α-HSD) and its involvement in the biosynthesis of epitestosterone
por: Bellemare, Véronique, et al.
Publicado: (2005)

Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer
por: Kraft, Peter, et al.
Publicado: (2005)

Analyses of Molecular Characteristics and Enzymatic Activities of Ovine HSD17B3
por: Islam, Mohammad Sayful, et al.
Publicado: (2021)

The Peroxisomal Localization of Hsd17b4 Is Regulated by Its Interaction with Phosphatidylserine
por: Lee, Sang-Ah, et al.
Publicado: (2021)

Adrenocortical oncocytoma associated with androgen excess: A rare cause of hirsutism
por: Prachi,, et al.
Publicado: (2021)

Overexpression of steroid sulfotransferase genes is associated with worsened prognosis and with immune exclusion in clear cell-renal cell carcinoma
por: Li, Yuqing, et al.
Publicado: (2019)

Coincident choroid plexus carcinoma and adrenocortical tumor in an infant
por: Yoshida, Kazuhiko, et al.
Publicado: (2012)

Adrenocortical carcinoma and pulmonary embolism from tumoral extension
por: Shekhar, Skand, et al.
Publicado: (2019)

Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success?
por: Georgantzoglou, Natalia, et al.
Publicado: (2021)

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
por: Spadaro, Alessandro, et al.
Publicado: (2012)

Mitotane in adrenocortical carcinoma.
por: Vassilopoulou-Sellin, R., et al.
Publicado: (1994)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2021)

11β-HSD Types 1 and 2 in the Songbird Brain
por: Rensel, Michelle A., et al.
Publicado: (2018)

Transcription start sites and epigenetic analysis of the HSD17B10 proximal promoter
por: Yang, Song-Yu, et al.
Publicado: (2013)

Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer
por: Huang, Huichao, et al.
Publicado: (2020)

Differential but Concerted Expression of HSD17B2, HSD17B3, SHBG and SRD5A1 Testosterone Tetrad Modulate Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2021)

Screening and Identification of Potential Prognostic Biomarkers in Adrenocortical Carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Untreated Congenital Adrenal Hyperplasia with 17-α Hydroxylase/17,20-Lyase Deficiency Presenting as Massive Adrenocortical Tumor
por: Lee, Su Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_str4u0d43mcb4pbudh8bu35s1r